GTA4: Enabler of Life Sciences Research?



By Salvatore Salamone

May 29, 2008 | Life sciences researchers should be thrilled. Earlier this month, the highly anticipated video game “Grand Theft Auto IV” (GTA4) was released and brought in more than $500 million in global sales in its first week. That’s about $200 million more than the blockbuster “Indiana Jones and the Kingdom of the Crystal Skull” made internationally in its first week out.

So what does the popularity of a new video game have to do with helping life scientists?

The success of a game like GTA4 will spur on the chip manufacturers and systems vendors to push the envelope to deliver better graphics and faster and smoother animation in the future. And while this processing power is being used by video games to deliver cool animation and graphics, it also is increasingly being tapped to conduct life sciences R&D.

For years, while CPUs kept pace with Moore’s Law to increase the computing power of servers and desktop computers, so too did the GPUs (graphics processing units), which are used to improve and accelerate rendering and animation. In fact, some argue that over the last few years GPU performance has outpaced that of CPUs.

Recent examples give a hint to the gains that can be made by tapping gaming processing power.

At last month’s Bio-IT World Expo in Boston, SimBioSys demonstrated a version of its eHiTS (Electronic High Throughput Screening) Lightning ligand docking software running on the Sony PlayStation 3 game console. Specifically, SimBioSys ported the software to run on the PS3’s guts, which is the microprocessor architecture called the Cell Broadband Engine (Cell/B.E.). The Cell/B.E was jointly developed by Sony, Toshiba, and IBM. It enables the PS3 to speed up physics simulations so that they can catch up with the 3D graphics rendering speeds of the system’s GPUs.

Essentially, by exploiting the parallel computer architecture of the Cell/B.E., SimBioSys dramatically speeds up the process of virtual screening and docking. In demonstrations, the eHiTS Lightning software application has been able to make throughput 30x faster than the application running on a traditional processor configuration.

Those who don’t own a PS3 can take advantage of similar speed benefits using an IBM BladeCenter QS21 blade server based on the same Cell/B.E. processor.

In their presentation at the Expo during the “Best of Show” judging, SimBioSys noted that a job that would take a 400 CPU cluster can be done on four IBM Cell blades or 10 PS3s.

One point to note: This isn’t the first venture into life sciences for the PS3. Starting in March 2007, users could download and run Folding@home software on their systems to help assist the Stanford University’s distributed computing protein-folding project.

Tapping Another Type of Gaming Power
Efforts like Folding@home and others have demonstrated the benefits of getting people to volunteer their idle computer cycles to help screen molecules and fold proteins. And many life sciences companies are tapping the same power of their desktop computers.

But even with the advances in high-performance computing and the additional computing power volunteers and office workers’ computers deliver, there are still many life sciences problems that require much more processing power.

To tackle just one problem – the folding of very large proteins – researchers at the University of Washington (UW) decided on a new strategy: Put the gamers to work.

In 2005, researchers at the university developed Rosetta@home, folding software that users downloaded to help find new proteins to fight diseases such as HIV, malaria, cancer, and Alzheimer's. The software works well for smaller proteins, but large proteins have too many variations in the way they can fold and thus require enormous amounts of computing power to simulate.

“There are too many possibilities for the computer to go through every possible one,” said David Baker, Rosetta@home developer and a UW professor of biochemistry and Howard Hughes Medical Institute investigator. “An approach like Rosetta@home does well on small proteins, but as the protein gets bigger and bigger it gets harder and harder, and the computers often fail. People, using their intuition, might be able to home in on the right answer much more quickly.”

With that idea in mind, researchers developed Foldit, a game where after about 20 minutes of training, users play along and use mouse clicks to help fold proteins.

Foldit is the first protein-folding project that asks volunteers for something other than unused processor cycles on their computers or PlayStation machines. It also differs from other interactive games that use a human’s ability to recognize images or interpret text. Instead, Foldit capitalizes on people's natural 3-D problem-solving skills.

The intuitive skills that make someone good at playing Foldit are not necessarily the ones that make a top biologist. Baker says his 13-year-old son is faster at folding proteins than he is.

With such efforts, perhaps the great interest in gaming and the success of popular games like GTA4 can be leveraged by the life sciences community to get more processing power for their simulations and more eyeballs to help refine 3D protein-folding puzzle solutions.

Do you use any distributed software applications that take advantage of your company’s unused computing cycles? What obstacles do you see in using such an approach? Are you looking into using the GPU processing power of your desktop computers? Drop me a note at s.salamone@att.net and share your thoughts on the subject.

 

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .